← FDA DRUG APPROVALS

FDA ANDA · ANDA075835

IPRATROPIUM BROMIDE

Sponsor: BAUSCH

APPLICATION
ANDA075835
TYPE
ANDA
ORIGINAL APPROVAL
2001-10-15
LATEST ACTION
2002-11-18
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

IPRATROPIUM BROMIDEDiscontinued
IPRATROPIUM BROMIDE 0.02% · SOLUTION · INHALATION

Approval history

2002-11-18Manufacturing (CMC) · Supplement 1AP
2002-10-02Manufacturing (CMC) · Supplement 2AP
2001-10-15OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →